Orthobiologic Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the orthobiologic market looks promising with opportunities in various applications, such as osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial & dental applications. The global orthobiologic market is expected to grow with a CAGR of 6%-9% from 2020 to 2025. The major drivers for this market are increasing incidence of sports injuries and road accidents, rising incidence of spinal diseases/disorders, and growing geriatric and obese population.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global orthobiologic market report, please download the report brochure.
In this market, viscosupplementation products is the largest product of orthobiologic, whereas hospitals is the largest end user. Growth in various segments of the orthobiologic market are given below:
The study includes trends and forecast for the global orthobiologic market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Viscosupplementation Products
DBM (Demineralized Bone Matrix)
Synthetic Orthobiologics
BMP (Bone Morphogenetic Protein)
Allografts
PRP (Platelet Rich Plasma)
BMAC (Bone Marrow Aspiration Concentrate)
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial and Dental Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Orthopedic Clinics & Ambulatory Care Centers
Research and Academic Institutes
Dental Clinics & Facilities
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the orthobiologics model companies profiled in this report include Bone Biologics, Medtronic Bioventus, Pioneer Surgical Technology, Smith & Nephew, Stryker, DePuy Synthes, Genzyme, Osiris Therapeutics, NuVasive, Zimmer Biomet, and Anthrex.
Lucintel forecasts that viscosupplementation will remain the largest product segment over the forecast period due to high adoption of the procedure, as it is associated with minimally invasive procedures with reduced pain and low cost.
Within this market, hospitals will remain the largest end user segment over the forecast period due to the increasing adoption of orthobiological products in a wide range of spinal and reconstructive surgeries performed in hospitals.
North America will remain the largest region over the forecast period due to the presence of a well-established healthcare market and growing geriatric population in the region.
Features of the Global Orthobiologic Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global orthobiologic market by product (viscosupplementation products, DBM, synthetic orthobiologics, BMP, allografts, PRP, and BMAC), application (osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial and dental applications), end user (hospitals, orthopedic clinics & ambulatory care centers, research and academic institutes, and dental clinics & facilities), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global orthobiologic market?
Q.5 What are the business risks and threats to the global orthobiologic market?
Q.6 What are the emerging trends in this orthobiologic market and the reasons behind them?
Q.7 What are some changing demands of customers in this orthobiologic market?
Q.8 What are the new developments in this orthobiologic market? Which companies are leading these developments?
Q.9 Who are the major players in this orthobiologic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this orthobiologic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global orthobiologic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments By Product (Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications), and End User (Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research & Academic Institutes, and Dental Clinics & Facilities)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the orthobiologic market looks promising with opportunities in various applications, such as osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial & dental applications. The global orthobiologic market is expected to grow with a CAGR of 6%-9% from 2020 to 2025. The major drivers for this market are increasing incidence of sports injuries and road accidents, rising incidence of spinal diseases/disorders, and growing geriatric and obese population.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global orthobiologic market report, please download the report brochure.
In this market, viscosupplementation products is the largest product of orthobiologic, whereas hospitals is the largest end user. Growth in various segments of the orthobiologic market are given below:
The study includes trends and forecast for the global orthobiologic market by product, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Viscosupplementation Products
DBM (Demineralized Bone Matrix)
Synthetic Orthobiologics
BMP (Bone Morphogenetic Protein)
Allografts
PRP (Platelet Rich Plasma)
BMAC (Bone Marrow Aspiration Concentrate)
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Osteoarthritis and Degenerative Arthritis
Spinal Fusion
Fracture Recovery
Soft Tissue Injuries
Maxillofacial and Dental Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals
Orthopedic Clinics & Ambulatory Care Centers
Research and Academic Institutes
Dental Clinics & Facilities
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the orthobiologics model companies profiled in this report include Bone Biologics, Medtronic Bioventus, Pioneer Surgical Technology, Smith & Nephew, Stryker, DePuy Synthes, Genzyme, Osiris Therapeutics, NuVasive, Zimmer Biomet, and Anthrex.
Lucintel forecasts that viscosupplementation will remain the largest product segment over the forecast period due to high adoption of the procedure, as it is associated with minimally invasive procedures with reduced pain and low cost.
Within this market, hospitals will remain the largest end user segment over the forecast period due to the increasing adoption of orthobiological products in a wide range of spinal and reconstructive surgeries performed in hospitals.
North America will remain the largest region over the forecast period due to the presence of a well-established healthcare market and growing geriatric population in the region.
Features of the Global Orthobiologic Market
- Market Size Estimates: Global orthobiologic market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global orthobiologic market size by various segments, such as product, application, and end user in terms of value.
- Regional Analysis: Global orthobiologic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product, application, end user, and region for the global orthobiologic market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global orthobiologic market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global orthobiologic market by product (viscosupplementation products, DBM, synthetic orthobiologics, BMP, allografts, PRP, and BMAC), application (osteoarthritis and degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, and maxillofacial and dental applications), end user (hospitals, orthopedic clinics & ambulatory care centers, research and academic institutes, and dental clinics & facilities), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global orthobiologic market?
Q.5 What are the business risks and threats to the global orthobiologic market?
Q.6 What are the emerging trends in this orthobiologic market and the reasons behind them?
Q.7 What are some changing demands of customers in this orthobiologic market?
Q.8 What are the new developments in this orthobiologic market? Which companies are leading these developments?
Q.9 Who are the major players in this orthobiologic market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this orthobiologic market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global orthobiologic market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments By Product (Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications), and End User (Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research & Academic Institutes, and Dental Clinics & Facilities)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Orthobiologic Market Trends and Forecast
3.3: Global Orthobiologic Market by Product
3.3.1: Viscosupplementation Products
3.3.2: DBM
3.3.3: Synthetic Orthobiologics
3.3.4: BMP
3.3.5: Allografts
3.3.6: PRP
3.3.7: BMAC
3.4: Global Orthobiologic Market by Application
3.4.1: Osteoarthritis and Degenerative Arthritis
3.4.2: Spinal Fusion
3.4.3: Fracture Recovery
3.4.4: Soft Tissue Injuries
3.4.5: Maxillofacial and Dental Applications
3.5: Global Orthobiologic Market by End User
3.5.1: Hospitals
3.5.2: Orthopedic Clinics & Ambulatory Care Centers
3.5.3: Research and Academic Institutes
3.5.4: Dental Clinics & Facilities
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Orthobiologic Market by Region
4.2: North American Orthobiologic Market
4.2.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.2.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.2.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.2.4: The United States Orthobiologic Market
4.2.5: The Canadian Orthobiologic Market
4.2.6: The Mexican Orthobiologic Market
4.3: European Orthobiologic Market
4.3.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.3.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.3.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.3.4: The United Kingdom Orthobiologic Market
4.3.5: The Spanish Orthobiologic Market
4.3.6: The German Orthobiologic Market
4.3.7: The French Orthobiologic Market
4.4: APAC Orthobiologic Market
4.4.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.4.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.4.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.4.4: The Chinese Orthobiologic Market
4.4.5: The Indian Orthobiologic Market
4.4.6: The Japanese Orthobiologic Market
4.5: ROW Orthobiologic Market
4.5.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.5.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.5.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.5.4: Brazilian Orthobiologic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Orthobiologic Market by Product
7.1.2: Growth Opportunities for the Global Orthobiologic Market by Application
7.1.3: Growth Opportunities for the Global Orthobiologic Market by End User
7.1.4: Growth Opportunities for the Global Orthobiologic Market by Region
7.2: Emerging Trends in the Global Orthobiologic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Orthobiologic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Orthobiologics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Bone Biologics, Corp
8.2: Medtronic
8.3: Bioventus LLC
8.4: Pioneer Surgical Technology
8.5: Smith & Nephew PLC
8.6: Stryker Corporation
8.7: DePuy Synthes, Inc.
8.8: Genzyme
8.9: NuVasive, Incl
8.10: Zimmer Biomet
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Orthobiologic Market Trends and Forecast
3.3: Global Orthobiologic Market by Product
3.3.1: Viscosupplementation Products
3.3.2: DBM
3.3.3: Synthetic Orthobiologics
3.3.4: BMP
3.3.5: Allografts
3.3.6: PRP
3.3.7: BMAC
3.4: Global Orthobiologic Market by Application
3.4.1: Osteoarthritis and Degenerative Arthritis
3.4.2: Spinal Fusion
3.4.3: Fracture Recovery
3.4.4: Soft Tissue Injuries
3.4.5: Maxillofacial and Dental Applications
3.5: Global Orthobiologic Market by End User
3.5.1: Hospitals
3.5.2: Orthopedic Clinics & Ambulatory Care Centers
3.5.3: Research and Academic Institutes
3.5.4: Dental Clinics & Facilities
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Orthobiologic Market by Region
4.2: North American Orthobiologic Market
4.2.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.2.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.2.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.2.4: The United States Orthobiologic Market
4.2.5: The Canadian Orthobiologic Market
4.2.6: The Mexican Orthobiologic Market
4.3: European Orthobiologic Market
4.3.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.3.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.3.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.3.4: The United Kingdom Orthobiologic Market
4.3.5: The Spanish Orthobiologic Market
4.3.6: The German Orthobiologic Market
4.3.7: The French Orthobiologic Market
4.4: APAC Orthobiologic Market
4.4.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.4.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.4.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.4.4: The Chinese Orthobiologic Market
4.4.5: The Indian Orthobiologic Market
4.4.6: The Japanese Orthobiologic Market
4.5: ROW Orthobiologic Market
4.5.1: Market by Product: Viscosupplementation Products, DBM, Synthetic Orthobiologics, BMP, Allografts, PRP, and BMAC
4.5.2: Market by Application: Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications
4.5.3: Market by End User: Hospitals, Orthopedic Clinics & Ambulatory Care Centers, Research and Academic Institutes, and Dental Clinics & Facilities
4.5.4: Brazilian Orthobiologic Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Orthobiologic Market by Product
7.1.2: Growth Opportunities for the Global Orthobiologic Market by Application
7.1.3: Growth Opportunities for the Global Orthobiologic Market by End User
7.1.4: Growth Opportunities for the Global Orthobiologic Market by Region
7.2: Emerging Trends in the Global Orthobiologic Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Orthobiologic Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Orthobiologics Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Bone Biologics, Corp
8.2: Medtronic
8.3: Bioventus LLC
8.4: Pioneer Surgical Technology
8.5: Smith & Nephew PLC
8.6: Stryker Corporation
8.7: DePuy Synthes, Inc.
8.8: Genzyme
8.9: NuVasive, Incl
8.10: Zimmer Biomet
